Humana Inc
NYSE:HUM
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
236.29
510.71
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Humana Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | US |
Market Cap | 35.7B USD |
Net Margin |
1%
|
Country | US |
Market Cap | 560.3B USD |
Net Margin |
4%
|
Country | US |
Market Cap | 105.1B USD |
Net Margin |
4%
|
Country | US |
Market Cap | 93.2B USD |
Net Margin |
4%
|
Country | US |
Market Cap | 30.6B USD |
Net Margin |
2%
|
Country | US |
Market Cap | 16.8B USD |
Net Margin |
3%
|
Country | US |
Market Cap | 9B USD |
Net Margin |
10%
|
Country | BR |
Market Cap | 22.7B BRL |
Net Margin |
-3%
|
Country | US |
Market Cap | 2.2B EUR |
Net Margin |
6%
|
Country | US |
Market Cap | 1.7B USD |
Net Margin |
-6%
|
Country | US |
Market Cap | 1.3B USD |
Net Margin |
5%
|
Humana Inc
Glance View
Humana Inc. is a leading healthcare company based in the United States, providing a robust portfolio of health insurance products and services. Founded in 1961, Humana has evolved into a key player in the Medicaid and Medicare markets, delivering a range of options that cater to individuals, families, and employers. The company’s innovative approach to health and wellness, along with its growing focus on integrated care models, positions it uniquely to meet the needs of an aging population and an increasingly diverse healthcare landscape. With a mission centered around improving health outcomes, Humana has developed a reputation for leveraging technology and data analytics to enhance patient care and streamline operations, which is crucial in maintaining its competitive edge in the industry. For investors, Humana represents a compelling opportunity as the demand for healthcare services continues to rise, driven by demographic shifts and the ongoing evolution of insurance models. The company has demonstrated consistent financial performance over the years, thanks to its strategic investments and a commitment to operational efficiency. Humana's recent initiatives into value-based care, coupled with partnerships and acquisitions, showcase its forward-thinking approach and dedication to sustainability. As the healthcare sector continues to innovate, Humana is well-positioned to navigate market challenges and opportunities, making it an intriguing prospect for those looking to invest in a resilient company with a solid growth trajectory.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Humana Inc's most recent financial statements, the company has Net Margin of 1.2%.